Grifols approves IPO of its US biopharma business

Grifols approves IPO of its US biopharma business | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv The logo of the Spanish pharmaceuticals company Grifols is pictured on theirs facilities in Parets del Valles, north of Barcelona, Spain, January 9, 2024. REUTERS/Albert Gea Purchase Licensing Rights, opens new tab Companies Grifols SA Our Standards: The Thomson Reuters Trust Principles., opens new tab Purchase Licensing Rights Busine ...